---
title: Procoagulant platelet activation promotes venous thrombosis
date: '2024-10-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39440970/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241023205824&v=2.18.0.post9+e462414
source: Blood
description: Platelets are key players in cardiovascular disease and platelet aggregation
  represents a central pharmacological target, particularly in secondary prevention.
  However, inhibition of adenosine diphosphate and thromboxane signaling has low efficacy
  in preventing venous thromboembolism, necessitating the inhibition of the plasmatic
  coagulation cascade in this disease. Anticoagulation carries a significantly higher
  risk of bleeding complications, highlighting the need of alternative ...
disable_comments: true
---
Platelets are key players in cardiovascular disease and platelet aggregation represents a central pharmacological target, particularly in secondary prevention. However, inhibition of adenosine diphosphate and thromboxane signaling has low efficacy in preventing venous thromboembolism, necessitating the inhibition of the plasmatic coagulation cascade in this disease. Anticoagulation carries a significantly higher risk of bleeding complications, highlighting the need of alternative ...